Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008052808> ?p ?o ?g. }
- W2008052808 endingPage "1366" @default.
- W2008052808 startingPage "1359" @default.
- W2008052808 abstract "DO was used in an aged mouse model to determine if systemically and/or locally administered rhIGF-I improved osteoblastogenesis and new bone formation. Local and systemic rhIGF-I treatment increased new bone formation. However, only systemic delivery produced measurable concentrations of rhIGF-I in the circulation.Human and rodent research supports a primary role for IGF-I in bone formation. Significant roles for both endocrine and paracrine/autocrine IGF-I have been suggested for normal osteoblastogenesis and bone formation. We have assessed, using a mouse model of distraction osteogenesis (DO), the impact of continuous administration of recombinant human (rh)IGF-I, delivered either locally to the distraction site or absorbed systemically, on bone formation in an aged mouse model.DO was performed in aged mice (18-month-old C57BL/6 male mice), which were distracted at 0.15 mm daily. At the time of osteotomy, miniosmotic pumps were inserted subcutaneously to (1) deliver vehicle or rhIGF-I subcutaneously for systemic delivery or (2) deliver vehicle or rhIGF-I directly to the newly forming bone through infusion tubing routed subcutaneously from the pump to the distraction site. Serum concentrations of mouse IGF-I, human IGF-I, and osteocalcin were determined at the end of the study.New bone formation observed in DO gaps showed a significant increase in new bone formation in rhIGF-I-treated mice, irrespective of delivery route. However, detectable levels of human IGF-I were found only in the serum of animals receiving rhIGF-I systemically. Osteocalcin levels did not differ between controls and rhIGF-I-treated groups.Locally and systemically delivered rhIGF-I both produce significant increases in new bone formed in an aged mouse model in which new bone formation is normally markedly impaired, suggesting that rhIGF-I may improve senile osteoporosis. Because systemic administration of IGF-I can result in untoward side effects, including an increased risk for cancer, the findings that locally delivered IGF-I improves bone regeneration without increasing circulating IGF-I levels suggests that this delivery route may be preferable in an at-risk, aged population." @default.
- W2008052808 created "2016-06-24" @default.
- W2008052808 creator A5020142407 @default.
- W2008052808 creator A5021089004 @default.
- W2008052808 creator A5028345100 @default.
- W2008052808 creator A5030656818 @default.
- W2008052808 creator A5034194433 @default.
- W2008052808 creator A5038467519 @default.
- W2008052808 creator A5042045435 @default.
- W2008052808 creator A5054845053 @default.
- W2008052808 creator A5070210677 @default.
- W2008052808 date "2006-09-01" @default.
- W2008052808 modified "2023-10-16" @default.
- W2008052808 title "Effects of Systemic and Local Administration of Recombinant Human IGF-I (rhIGF-I) on De Novo Bone Formation in an Aged Mouse Model" @default.
- W2008052808 cites W1560657722 @default.
- W2008052808 cites W1562667342 @default.
- W2008052808 cites W1569741533 @default.
- W2008052808 cites W1965493026 @default.
- W2008052808 cites W1970349847 @default.
- W2008052808 cites W1975139962 @default.
- W2008052808 cites W1976195996 @default.
- W2008052808 cites W1976718154 @default.
- W2008052808 cites W1984202709 @default.
- W2008052808 cites W1985319851 @default.
- W2008052808 cites W1992460009 @default.
- W2008052808 cites W1993672117 @default.
- W2008052808 cites W1995715562 @default.
- W2008052808 cites W1999561771 @default.
- W2008052808 cites W1999884560 @default.
- W2008052808 cites W2001184676 @default.
- W2008052808 cites W2003016121 @default.
- W2008052808 cites W2006345660 @default.
- W2008052808 cites W2007657701 @default.
- W2008052808 cites W2014264595 @default.
- W2008052808 cites W2017442945 @default.
- W2008052808 cites W2017949036 @default.
- W2008052808 cites W2019080354 @default.
- W2008052808 cites W2032684969 @default.
- W2008052808 cites W2042108419 @default.
- W2008052808 cites W2043498363 @default.
- W2008052808 cites W2044856415 @default.
- W2008052808 cites W2048411278 @default.
- W2008052808 cites W2051485576 @default.
- W2008052808 cites W2053544048 @default.
- W2008052808 cites W2060018931 @default.
- W2008052808 cites W2068654254 @default.
- W2008052808 cites W2068667158 @default.
- W2008052808 cites W2071340939 @default.
- W2008052808 cites W2072514327 @default.
- W2008052808 cites W2078455816 @default.
- W2008052808 cites W2084713335 @default.
- W2008052808 cites W2090277249 @default.
- W2008052808 cites W2092989780 @default.
- W2008052808 cites W2104668613 @default.
- W2008052808 cites W2111144663 @default.
- W2008052808 cites W2113564705 @default.
- W2008052808 cites W2113777483 @default.
- W2008052808 cites W2115384001 @default.
- W2008052808 cites W2122954559 @default.
- W2008052808 cites W2133725782 @default.
- W2008052808 cites W2138117830 @default.
- W2008052808 cites W2149726839 @default.
- W2008052808 cites W2155907836 @default.
- W2008052808 cites W2157254321 @default.
- W2008052808 cites W2166044131 @default.
- W2008052808 cites W2170643858 @default.
- W2008052808 cites W2172818901 @default.
- W2008052808 cites W2402314386 @default.
- W2008052808 cites W2417960026 @default.
- W2008052808 cites W292398390 @default.
- W2008052808 cites W4230802353 @default.
- W2008052808 cites W4233984730 @default.
- W2008052808 cites W4236128778 @default.
- W2008052808 cites W4241469733 @default.
- W2008052808 cites W4246162776 @default.
- W2008052808 cites W4249409065 @default.
- W2008052808 cites W4253353943 @default.
- W2008052808 cites W4255221283 @default.
- W2008052808 doi "https://doi.org/10.1359/jbmr.060618" @default.
- W2008052808 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2424402" @default.
- W2008052808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16939394" @default.
- W2008052808 hasPublicationYear "2006" @default.
- W2008052808 type Work @default.
- W2008052808 sameAs 2008052808 @default.
- W2008052808 citedByCount "66" @default.
- W2008052808 countsByYear W20080528082012 @default.
- W2008052808 countsByYear W20080528082013 @default.
- W2008052808 countsByYear W20080528082014 @default.
- W2008052808 countsByYear W20080528082015 @default.
- W2008052808 countsByYear W20080528082017 @default.
- W2008052808 countsByYear W20080528082018 @default.
- W2008052808 countsByYear W20080528082019 @default.
- W2008052808 countsByYear W20080528082020 @default.
- W2008052808 countsByYear W20080528082021 @default.
- W2008052808 countsByYear W20080528082022 @default.
- W2008052808 countsByYear W20080528082023 @default.
- W2008052808 crossrefType "journal-article" @default.
- W2008052808 hasAuthorship W2008052808A5020142407 @default.